| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $75.6B | $70.6B | $65.0B | $60.2B | $58.8B | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $6.8B | $5.8B | $5.2B | $5.6B | $7.0B | $3.8B | $1.1B | $1.1B |
| EPS (Basic) | $28.70 | $22.27 | $19.25 | $19.43 | $21.52 | $11.10 | $3.16 | $3.09 |
| EPS (Diluted) | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 | $10.93 | $3.09 | $3.01 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $60.7B | $59.5B | $56.2B | $52.4B | $50.7B | $47.5B | $45.1B | $39.2B |
| Current Assets | $15.8B | $16.4B | $14.9B | $13.6B | $13.5B | $12.3B | $11.2B | $10.2B |
| Cash & Equivalents | $1.0B | $1.9B | $0.9B | $0.9B | $1.5B | $1.8B | $0.6B | $0.5B |
| Total Liabilities | — | — | — | — | — | — | $45.6B | $42.1B |
| Current Liabilities | $16.4B | $15.2B | $12.7B | $9.9B | $9.6B | $8.7B | $7.8B | $7.6B |
| Stockholders' Equity | $-6.0B | $-2.5B | $-1.8B | $-2.8B | $-0.9B | $0.6B | $-2.8B | $-5.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $12.6B | $10.5B | $9.4B | $8.5B | $9.0B | $9.2B | $7.6B | $6.8B |
| Investing Cash Flow | $-5.0B | $-4.9B | $-5.3B | $-3.4B | $-2.6B | $-3.4B | $-5.7B | $-3.9B |
| Capital Expenditures | $4.9B | $4.9B | $4.7B | $4.4B | $3.6B | $2.8B | $4.2B | $3.6B |
| Financing Cash Flow | $-8.6B | $-4.6B | $-4.1B | $-5.7B | $-6.7B | $-4.7B | $-1.8B | $-3.1B |